|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02609 BAYZED HEALTH
Nominal 
2.805 +0.025 (+0.899%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 584,453 | 1.692% | 1,119,849 | 1,188,846 | 1,072,173 | 802,652 |
| Cost of Sales | (475,862) | 1.596% | (929,037) | (980,649) | (894,009) | (723,095) |
| Gross Profit | 108,591 | 2.111% | 190,812 | 208,197 | 178,164 | 79,557 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 25,821 | -- | 9,292 | 13,312 | (4,610) | (62,524) | |
| Taxation | (7,354) | -27.860% | (17,970) | (16,869) | (19,796) | (12,991) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (4,049) | -44.971% | (4,279) | (9,900) | (1,983) | 17,497 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 14,418 | -- | (12,957) | (13,457) | (26,389) | (58,018) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 9,753 | -7.176% | 17,553 | 18,837 | 25,851 | 23,120 |
| Depreciation & Amortisation | 53,166 | 19.517% | 90,916 | 87,396 | 86,271 | 74,544 |
| Directors' Emoluments | -- | -- | -- | 6,570 | 5,994 | 5,109 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 1.000 | -- | -1.000 | -1.000 | -- | -- |
| DPS (cts) | 0.000 | -- | 0.000 | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.177 | 0.142 | -- | -- |
| NBV per share ($) | 1.154 | -- | 1.153 | -- | -- | -- |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 14,418 |
| %Change | -- |
| EPS / (LPS) | RMB 0.010 |
| NBV Per Share (¥) | RMB 1.154 |